Cardiogenic shock (CS) is a complex multifactorial clinical syndrome with extremely high
mortality, develo** as a continuum, and progressing from the initial insult (underlying …

Cardiogenic shock (CS) remains the most common cause of death in patients admitted with
acute myocardial infarction (AMI) and mortality remained nearly unchanged in the range of …

Background Extracorporeal life support (ECLS) is increasingly used in the treatment of
infarct-related cardiogenic shock despite a lack of evidence regarding its effect on mortality …

Background Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly
used in patients with cardiogenic shock despite the lack of evidence from adequately …

Background: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is
increasingly used to treat cardiogenic shock. However, VA-ECMO might hamper myocardial …

Background Cardiogenic shock (CS) is a heterogeneous syndrome with varied
presentations and outcomes. We used a machine learning approach to test the hypothesis …

Background: Risk stratifying patients with cardiogenic shock (CS) is a major unmet need.
The recently proposed Society for Cardiovascular Angiography and Interventions (SCAI) …

Cardiogenic shock can occur due to acute ischaemic or non-ischaemic cardiac events, or
from progression of long-standing underlying heart disease. When addressing the cause of …

See page 49 for disclosure information. List of abbreviations: ACT, activated clotting time;
aPTT, activated partial thromboplastin time; ACHD, adult congenital heart disease; ADHF …

Despite increasing prevalence in critical care units, cardiogenic shock related to HF (HF-CS)
is incompletely understood and distinct from acute myocardial infarction related CS. This …